2026-03-20 • pulmonaryhypertensionnews.com
Cereno receives approval to begin Phase 1 trial for CS014 a possible treatment for PH-ILD
2026-03-20 • pulmonaryhypertensionnews.com
Cereno receives approval to begin Phase 1 trial for CS014 a possible treatment for PH-ILD2026-03-20 • investingnews.com
Pliant Therapeutics will present Phase 1 clinical trial data of PLN-101095 for solid tumors at the 2026 AACR Annual Meeting.2026-03-19 • PR Newswire
Congruence Initiates Initial Treatment Administration in Phase 1/1b Clinical Trial Featuring CGX-926 a Novel Oral MC4R Corrector Targeting Genetic Obesity2026-03-19 • manilatimes.net
Arvinas Reports Encouraging Phase 1 Results with ARV-102 Demonstrating Over 50% LRRK2 Reduction in Parkinson’s Disease Patient Cerebrospinal Fluid After2026-03-19 • gurufocus.com
Ovid Therapeutics OVID plans to initiate Phase 1 testing of drug OV40712026-03-19 • gurufocus.com
Arvinas ARVN Announces Positive Phase 1 Trial Findings for ARV-102 for Parkinson’s Disease2026-03-19 • bitget.com
Arvinas Reports Encouraging Phase 1 Results with ARV-102 Demonstrating Over 50% LRRK2 Reduction in Parkinson’s Disease Patient Cerebrospinal Fluid After2026-03-19 • stocktitan.net
Ovid Therapeutics Reveals OV329 Data and Broader Use, Phase 1 Approval for OV4071, and Publishes 2025 Financials2026-03-19 • stocktitan.net
MetaVia’s DA-1726 obesity program progresses as the company initiates a Phase 1 trial receiving IRB approval for a higher dose.2026-03-19 • pmlive.com
Atrogi advances to phase 1 trial of its oral drug for metabolic and muscle health enhancement2026-03-18 • PR Newswire
MetaVia’s GLP-1 program progresses with IRB clearance to initiate Phase 1 studies of DA-1726, a GLP-1 and glucagon dual agonist, showcasing superior2026-03-18 • manilatimes.net
Liminatus Pharma is set to conduct a Phase 1 clinical trial for IBA101, a new CD47 blocking antibody.2026-03-18 • PR Newswire
GentiBio Reports Initial Patient Received GNTI-122 in POLARIS Phase 1 Trial for Newly Diagnosed Type 1 Diabetes2026-03-18 • PR Newswire
Brenig Therapeutics will present Phase 1 data for BT-267 in an oral session at AD/PD™ 2026, and also offers updates regarding its BT-402026-03-17 • businesswire.com
Enolen Phase 1 Trial Shows Promising Initial Safety and Effectiveness Results for Alessa Therapeutics2026-03-17 • businesswire.com
Helical Fusion Initiates Phase 1 Construction of “Helix HARUKA,” Signaling a Move to Fusion Hardware Production and Assembly2026-03-17 • asiae.co.kr
Regenerative Therapy Utilizing Organoid Science Gains IND Approval for Phase 1 Trial2026-03-16 • EIN Presswire
NordSpace Awarded Phase 1 $8.3 Million from Department of National Defence to Develop Sovereign Space Launch Capabilities2026-03-16 • parkinsonsnewstoday.com
Immunis intends to conduct a Phase 1 trial of a treatment for Parkinson’s dyskinesia2026-03-14 • alsnewstoday.com
Insmed initiates Phase 1 trial of INS1202 gene therapy for ALS under the MDA 2026 program.2026-03-13 • bitget.com
Solid Biosciences Reports Encouraging Early Clinical Data from Phase 12 INSPIRE DUCHENNE Trial2026-03-12 • quiverquant.com
Arvinas Inc. will share Phase 1 trial results for ARV-102 in Parkinson’s Disease at the AD/PD 2026 event.2026-03-11 • bitget.com
SpyGlass Pharma Reports Positive 12-Month Phase 12 Trial Outcomes for the BIM-IOL System2026-03-11 • stocktitan.net
SAB BIO Reports Further Phase 1 Results for SAB-142 in Grown-Up Type 1 Diabetes Individuals2026-03-11 • stocktitan.net
NKGen Biotech will showcase combined Phase 1 clinical and biomarker data for Troculeucel regarding Alzheimer’s Disease at AD/PD™ 20262026-03-10 • PR Newswire
Citius Oncology Reports Encouraging Findings from LYMPHIR™ Phase 1 Study with Pembrolizumab for Advanced Gynecologic Cancers2026-03-10 • globenewswire.com
SpyGlass Pharma Reports Positive 12-Month Phase 12 Trial Outcomes for the BIM-IOL System2026-03-09 • PR Newswire
AbbVie Reports Encouraging Phase 1 Data for ABBV-295, a Long-Acting Amylin Analog, in Adult Patients2026-03-09 • PR Newswire
IDEAYA Biosciences Reports Initial Patient Enrollment in Phase 1 Trial of IDE892, a Promising PRMT5 Inhibitor Targeting MTAP-Deleted Cancers, Alongside MTAP and CDKN22026-03-09 • freepressjournal.in
Ramky Infrastructure Wins ₹1,401 Crore EPC Contract for Dighi Port Industrial Area Phase 1 as Part of the DMIC Project in Maharashtra26 minutes ago • prnewswire.co.uk
Consumer Genius Accelerates Growth in North American Insurance and Auto Lending Sectors, Plans Entry into Home Services and Solar Markets1 hour ago • prnewswire.co.uk
Public Launches Crypto Trading in IRAs2 hours ago • prnewswire.co.uk
WBS Power Advances 3.2 GW Energy Infrastructure for Hyperscale Data Center Campus3 hours ago • prnewswire.co.uk
Morgan Wilson Launches The Wilson Co. to Bring a Human Edge Back to Career Strategy and Talent Development6 hours ago • prnewswire.co.uk
Digital Dentistry Market to Reach US$ 13.7 Billion by 2033 Expands Amid Rapid Technological Adoption and Precision Care Demand - Persistence Market Research6 hours ago • prnewswire.co.uk
A Success Story - DelveInsight's Strategic Support to a Pharma Company in Interleukin-2 Target Patient Pool and Epidemiology-based Market Forecast Analysis7 hours ago • prnewswire.co.uk
NYSE Announces: The Hill and Valley Forum Hosts Executives in Washington8 hours ago • prnewswire.co.uk
Athena Intelligence Announces India Expansion Facing Increased Border Corporate Threats10 hours ago • prnewswire.co.uk
Bybit Trading Bots Now Available for Stocks, Increasing Automated Trading of Tokenized Securities22 hours ago • prnewswire.co.uk
Paratus Energy Services Ltd. Reports Sale of Jack-up Operations23 hours ago • prnewswire.co.uk
Food Testing Market Forecasts USD 29.43 Billion Reach by 2032 Due to Increasing Food Safety Worries, Says MarkNtel Advisors2026-03-23 • kbc.co.ke
Nairobi Eastland’s water crisis addressed by a Ksh 1.4 billion project11 minutes ago • EIN Presswire
Inflation-Resistant Alternative Currency, Goldback, Launching for Everyday Consumer Use in Idaho11 minutes ago • EIN Presswire
Breaking the Script: Nyerere K. Billups, Sr., The Growfessor™, Launches Unscripting and Sparks a Movement26 minutes ago • EIN Presswire
TransformFitAI Founder Launches Privacy-First Solution to the 'Invisible' Fitness Crisis for Women 40+7 hours ago • PR Newswire
Cipla Health Expands ProlyteORS Range Featuring Masala Guava Taste10 hours ago • PR Newswire
Protean Digital Disruptors 2026 honors innovators driving India’s future financial system12 hours ago • PR Newswire
The Protean 'Digital Disruptors 2026' award recognizes innovative leaders transforming India’s financial sector.3 hours ago • EIN Presswire
Tecla Languages Receives Outstanding Customer Experience in Study Abroad Programs 2026 Award4 hours ago • EIN Presswire
tigerlab Launches AI-Native Broker Management System Across 30+ Countries5 hours ago • EIN Presswire
BlueKong Networks unveils BlueKong Go — an On-Demand Platform set to transform IT Field Services.Stay ahead with real-time headlines from top sources, categorized by sector and country.